[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,276
  • Shares Outstanding, K 8,718
  • Annual Sales, $ 3,850 K
  • Annual Income, $ -8,490 K
  • EBIT $ -14 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.39
  • Price/Sales 1.68
  • Price/Cash Flow N/A
  • Price/Book 0.54
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.92
  • Most Recent Earnings $-0.61 on 03/05/26
  • Next Earnings Date 05/20/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6600 +5.06%
on 05/21/26
0.8500 -18.42%
on 05/07/26
-0.1066 (-13.32%)
since 04/21/26
3-Month
0.6600 +5.06%
on 05/21/26
0.9700 -28.52%
on 03/23/26
-0.1273 (-15.51%)
since 02/20/26
52-Week
0.6600 +5.06%
on 05/21/26
2.4200 -71.35%
on 06/10/25
-0.4916 (-41.49%)
since 05/21/25

Most Recent Stories

More News
Evogene: Q1 Earnings Snapshot

Evogene: Q1 Earnings Snapshot

EVGN : 0.6934 (-3.68%)
Evogene Reports First Quarter 2026 Financial Results

Conference call and webcast: today, May 20, 2026, 9:00 AM ET

EVGN : 0.6934 (-3.68%)
Evogene to Present at the 24th Schrödinger European User Group Meeting

Conference will be held in Munich, Germany - May 19-21, 2026

EVGN : 0.6934 (-3.68%)
Evogene Schedules First Quarter 2026 Financial Results Release

Zoom conference call scheduled for May 20, 2026, 9:00 AM ET

EVGN : 0.6934 (-3.68%)
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

REHOVOT, Israel , April 2, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ : EVGN)(TASE: EVGN) (the " Company ", " Evogene "), a pioneering company in computational chemistry, specializing...

EVGN : 0.6934 (-3.68%)
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock

Today, castor oil is a premium sustainable industrial feedstock for bio-based products

EVGN : 0.6934 (-3.68%)
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026

Conference will be held at Lisbon, Portugal - March 23–25, 2026

EVGN : 0.6934 (-3.68%)
Evogene: Q4 Earnings Snapshot

Evogene: Q4 Earnings Snapshot

EVGN : 0.6934 (-3.68%)
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results

Conference call and webcast: today, March 05, 2026, 9:00 AM ET

EVGN : 0.6934 (-3.68%)
Evogene Releases CEO Letter to Shareholders

Updating on Strategic Progress and Outlook

EVGN : 0.6934 (-3.68%)

Business Summary

Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene...

See More

Key Turning Points

3rd Resistance Point 0.7939
2nd Resistance Point 0.7605
1st Resistance Point 0.7269
Last Price 0.6934
1st Support Level 0.6599
2nd Support Level 0.6265
3rd Support Level 0.5929

See More

52-Week High 2.4200
Fibonacci 61.8% 1.7477
Fibonacci 50% 1.5400
Fibonacci 38.2% 1.3323
Last Price 0.6934
52-Week Low 0.6600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.